Takayasu's arteritis progression on anti-TNF biologics: A case series

Clinical Rheumatology

Volumn 30, Issue 5, 2011, Pages 703-706

  Osman, Mohammed ^a   Aaron, Stephen ^a   Noga, Michelle ^a   Yacyshyn, Elaine ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anti TNF biologics; Crohn's disease; Infliximab; Takayasu's arteritis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; FOLIC ACID; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ADOLESCENT; ADULT; ANAMNESIS; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; LABORATORY TEST; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; REMISSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; BIOLOGICAL PRODUCTS; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; REMISSION INDUCTION; TAKAYASU ARTERITIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959687659     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-010-1658-1     Document Type: Article

References (18)

1. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369(9573):1641-5167
2. Reny JL et al (2003) Association of Takayasu's arteritis and Crohn's disease: results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris) 154(2):85-90
3. Chung SA, Seo P (2009) Advances in the use of biologic agents for the treatment of systemic vasculitis. Curr Opin Rheumatol 21(1):3-9
4. Maffei S et al (2009) Refractory Takayasu arteritis successfully treated with infliximab. Eur Rev Med Pharmacol Sci 13(1):63-65
5. Molloy ES et al (2008) Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67(11):1567-1569
6. Filocamo G et al (2008) Treatment of Takayasu's arteritis with tumor necrosis factor antagonists. J Pediatr 153(3):432-434
7. Wolbink GJ et al (2005) Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64(5):704-707 (Pubitemid 40559296)
8. St Clair EW et al (2002) The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, doubleblind, placebo-controlled trial. Arthritis Rheum 46(6):1451-1459
9. Wolbink GJ et al (2006) Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. Arthritis Rheum 54(3):711-715
10. Baert F et al (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 348 (7):601-608 (Pubitemid 36204954)
11. Bartelds GM et al (2010) Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-TNF naive patients: a cohort study. Ann Rheum Dis 69(5):817-821
12. El-Matary W, Persad R (2009) Takayasu's aortitis and infliximab. J Pediatr 155(1):151
13. Farrant M et al (2008) Takayasu's arteritis following Crohn's disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol 14(25):4087-4090
14. Levitsky J, Harrison JR, Cohen RD (2002) Crohn's disease and Takayasu's arteritis. J Clin Gastroenterol 34(4):454-456 (Pubitemid 34258327)
15. Owyang C et al (1979) Takayasu's arteritis in Crohn's disease. Gastroenterology 76(4):825-828 (Pubitemid 9153464)
16. Friedman CJ, Tegtmeyer CJ (1979) Crohn's disease associated with Takayasu's arteritis. Dig Dis Sci 24(12):954-958 (Pubitemid 10217936)
17. Johnston SL, Lock RJ, Gompels MM (2002) Takayasu arteritis: a review. J Clin Pathol 55(7):481-486 (Pubitemid 34779296)
18. Karlinger K et al (2000) The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35(3):154-167